DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.79−0.54 (-5.79%)
Close on Nov 13, 2026Market cap $474.01MP/E –Yield –
DiaMedica Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
DiaMedica Therapeutics's market cap was $520.92M on Nov 11, 2026, against $449.43M a year earlier. Over the last 5 years it ranged from $31.20M to $520.92M, with a median of $114.33M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $520.92M | +25.7% |
| 2025 | Dec 31, 2025 | $414.54M | +78.5% |
| 2024 | Dec 31, 2024 | $232.22M | +115.4% |
| 2023 | Dec 29, 2023 | $107.79M | +158.0% |
| 2022 | Dec 30, 2022 | $41.78M | -57.6% |
| 2021 | Dec 31, 2021 | $98.62M | -48.1% |
| 2020 | Dec 31, 2020 | $190.01M | +226.3% |
| 2019 | Dec 31, 2019 | $58.23M | +214.1% |
| 2018 | Dec 31, 2018 | $18.54M | – |
See a number that looks wrong?